Icahn Wins Blue Ribbon in ImClone Race (IMCL, LLY, BMY, MRK)
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading up on a very weak trading day after what many had deemed as a…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 349OSI Phase III Falls Short (OSIP, DNA)
OSI Pharmaceuticals Inc. (NASDAQ: OSIP) is getting hit hard in early trading this morning. The biotech has released data showing that a Phase III trial of Genentech’s (NYSE: DNA) Avastin combined with Tarceva in…
Biotech Implosion: CombinatoRx (CRXX)
CombinatoRx, Incorporated (NASDAQ: CRXX) is seeing its stock implode this morning. The company released data from its Phase IIb study of Synavive (CRx-102) for knee osteoarthritis showing that its Synavive test was not statistically…
Boston Scientific (BSX) Slaughters It Shareholders Again
The list of management screw-ups at Boston Scientific (BSX) is almost too long to number. It bought rival Guidant and added $7 billion in debt in the process. Some of Guidant’s products were not…
UBS Taking Down Hospital Stocks (CYH, THC, UHS)
UBS has decided to downgrades the hospital sector this morning. It seems that perhaps not all medical and healthcare stocks are immune from a rapidly weakening economy. We have seen downgrades on three of…
Cardinal Health To Spin Off Med Tech (CAH)
Cardinal Health, Inc. (NYSE: CAH) is going to shuffle things up. The healthcare products and services company plans a tax-free spin-off of its clinical and medical products businesses as a separate public company. The…
Fluidigm IPO Shelved
It appears that the IPO market has lost another IPO. Fluidigm Corp. was set to come public. We had it on the docket last week, then this week. Now it appears to be postponed…
Biotech Bonanza: Ligand Takes out Pharmacopeia (LGND, PCOP)
This might not be the biggest of biotech mergers out there, but deals are continuing in the bio-space. Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has entered into a definitive merger agreement to acquire Pharmacopeia (NASDAQ:…
Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)
ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps an unofficial deal waiting in the wings. Bristol-Myers Squibb Co. (NYSE: BMY) has now…
Day Trader Alert: Gilead Sciences (GILD)
Gilead Sciences Inc. (NASDAQ: GILD) is trading down this morning. Goldman Sachs maintained its buy rating on the stock, but took down its price target to $58 from $59. This report is after a…
Abbott (ABT): A Resurrection Of The Stent Business
The stent business in the US has been dying and it is in trouble overseas. Stents are small mesh tubs which keep clogged arteries open. Last year, several studies showed that stents could cause…
Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)
There is some very hopeful data out there this morning on cancer survival. Bristol-Myers Squibb Co. (NYSE: BMY) and Medarex, Inc. (NASDAQ: MEDX) have released updated survival data from three Phase II studies of…
Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)
Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its buyout offer. It said it is disappointed that the $60.00 bid was passed up…
Day Trader Alert: ImClone Systems (IMCL, BMY)
ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The company has said that the proposed $60.00 per share cash buyout from Bristol-Myers Squibb…
Cardica Adding U.S. to E.U. & Japan Sales (CRDC)
A usually quiet Cardica, Inc. (NASDAQ: CRDC) is seeing a huge move in its stock today on strong upside volume. The company has won FDA marketing approval to sell its PAS-Port Proximal Anastomosis System…